Ramipril for COVID-19
Serious outcome risk
Outcome (studies)
Improvement
Relative risk · 95% CI
All studies (1)−144%
Mortality (1)−144%
Ventilation (1)−289%
ICU admission (1)−289%
RCTs (1)−144%
Late (1)−144%